Ampersand Capital Partners

Lexington Medical, Inc., founded in 2013 and based in Watertown, Massachusetts, specializes in the development and manufacture of medical devices, particularly minimally invasive surgical stapling solutions. The company focuses on creating innovative surgical instruments that enhance hemostatic stapling across various procedures, such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy. By prioritizing high standards in design engineering and smart manufacturing, Lexington Medical aims to improve the efficiency of surgical operations, thereby providing health care providers and their patients with reliable outcomes.

VIVEbiotech specializes in the development and manufacturing of lentiviral vectors, adhering to regulatory guidelines set by the EMA and FDA. The company provides contract development and manufacturing services tailored to meet the specific needs of its clients. VIVEbiotech's lentiviral vectors are employed in the treatment of various conditions, including hematological cancers, solid tumors, and rare diseases. By offering personalized services that include vector design and cloning tools, VIVEbiotech supports clients in conducting tests and research related to these challenging health issues.

Avid Bioservices is a contract development and manufacturing organization (CDMO) specializing in biopharmaceutical products. It offers a range of services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. The company focuses on quality and expertise, tailoring its services to meet the unique needs of its clients, primarily pharmaceutical and biotechnology companies. By outsourcing to Avid Bioservices, these companies can accelerate the development and manufacturing of their biologics, ultimately expediting the delivery of new therapies to patients.

Nektar Therapeutics is a biopharmaceutical company based in San Francisco, California, with additional operations in Huntsville, Alabama, and Hyderabad, India. The company focuses on researching and developing investigational drugs for oncology, immunology, and virology, alongside a portfolio of partnered approved medicines. Its clinical pipeline includes notable candidates such as NKTR-181 for chronic low back pain, ONZEALD for advanced metastatic breast cancer, and Bempegaldesleukin, designed to enhance cancer-killing T cell activity. Nektar is also developing therapies for autoimmune diseases, including NKTR-358, and various other conditions like hemophilia A, opioid-induced constipation, and systemic lupus erythematosus. The company's strategy involves leveraging the immune system to combat cancer and restore immune balance in autoimmune disorders. Nektar has established collaboration agreements with several major pharmaceutical companies, enhancing its research capabilities and development efforts. Incorporated in 1990, Nektar Therapeutics continues to advance its innovative drug candidates through various stages of clinical trials.

Biologos, LLC, established in 1976 and headquartered in Montgomery, Illinois, specializes in the manufacturing of sterile filtered and irradiated solutions, including sera, enzyme solutions, and balanced salt solutions. The company provides a range of products, such as standard and custom cell culture media and reagents, which are essential for supporting cell growth in artificial environments. Biologos has built a reputation as a trusted provider of biological solutions, having shipped over 7 million liters of product globally and serving more than 200 tissue banks and leading animal health companies in the United States. The firm's commitment to quality and rapid product formulation and distribution has positioned it as a significant contributor to advancements in health and wellness.

Specac International specializes in the manufacturing of spectroscopic accessories, primarily serving industries such as forensic science, life sciences, pharmaceuticals, research, and quality control. Founded in 1954, the company has evolved to meet the needs of academic, industrial, and research institutions worldwide by providing innovative and reliable infrared (IR) and Fourier-transform infrared (FTIR) sample handling devices. Its diverse product range includes spectrometers, kits, wire grid polarizers, reflectance and microscopy accessories, transmission windows, and hydraulic presses, catering to various applications in atomic and molecular spectroscopy. With a strong commitment to quality and innovation, Specac has established a global reputation, becoming a trusted partner for spectroscopists seeking advanced solutions in their fields.

Julius Clinical specializes in distinct therapeutic areas that offer a full-service proposal or separate functional service.

ProtaGene is an analytical service provider specializing in the biopharmaceutical sector, particularly in the development of biologic therapeutics and cell and gene therapies. The company offers a comprehensive suite of protein and gene analytic capabilities, catering to the needs of biosimilar developers by facilitating the demonstration of biosimilarity. ProtaGene's services include peptide mapping, protein quantification, protein modification analysis, bioassays, impurity assessment, and detailed characterization of antibodies and related products. These offerings are designed to support clients throughout the product lifecycle, enabling advanced analytics that enhance biopharmaceutical development processes.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.

NanoImaging Services, Inc. is a provider of transmission electron microscopy imaging and analysis services, catering to the pharmaceutical, biotechnology, and nanotechnology sectors. Established in 2007 and headquartered in San Diego, California, the company specializes in a range of services including sizing and counting, characterization of sub-micron aggregates, liposomes, emulsions, proteins, and viruses, as well as 3D structure determination. With a strong focus on client collaboration and expertise, NanoImaging Services has developed a reputation for reliability within its field. The company has invested in state-of-the-art facilities equipped with advanced electron microscopes and computational infrastructure, enabling them to support structural biology, nanoparticle characterization, and good manufacturing practices. Through recent expansions, NanoImaging Services has positioned itself as a leading provider of transmission electron microscopy and cryo-electron microscopy services within the industrial life science market, serving clients across North America, Europe, Asia, and beyond.

Iuvo is a contract research organization that provides preclinical testing, clinical research, and consulting services to the healthcare sector.

AcuraBio is a contract development and manufacturing organization that specializes in providing services to the pharmaceutical, biotechnology, and veterinary sectors. The company offers a range of products, including recombinant proteins, vaccines, and complex live biotherapeutic products. By focusing on quality, cost-effectiveness, and intellectual property assurances, AcuraBio supports its clients in the development and market introduction of innovative therapeutics.

Phosphorex is a prominent contract development and manufacturing organization that focuses on sustained release formulation, nanomedicine, and the delivery of nucleic acids. Established in 2005, the company collaborates with the biomedical community to create a range of microparticles, nanoparticles, and particle-based pharmaceutical formulations. Phosphorex provides comprehensive services, including formulation, feasibility studies, optimization, and process development of polymeric particles. By optimizing drug release rates, targeting capabilities, and bioavailability, the company aids pharmaceutical and biotechnology firms in enhancing therapeutic effects while minimizing adverse clinical outcomes.

Sterling Medical Devices is a custom electro-mechanical and software solution provider for the medical device industry.

AnaBios is a contract research organization (CRO) focused on enhancing drug discovery through human-centric methodologies. The company utilizes proprietary technology that leverages human donor organs and tissues to examine ex vivo human responses to drugs, thereby deepening the understanding of human physiology's molecular and functional aspects. Its research primarily targets significant unmet medical needs, including cardiac disease, pain management, polycystic kidney disease, and neurodegeneration. By generating valuable predictive human data prior to clinical trials, AnaBios aids pharmaceutical companies, contract research organizations, and academic institutions in selecting the most effective and safest drugs, ultimately reducing the time and costs associated with clinical trial failures. Through collaborations with Fortune 500 companies, AnaBios aims to facilitate therapeutic advancements that contribute to improved patient outcomes and wellbeing.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.

Syft Technologies Ltd. specializes in the development and support of advanced air analysis solutions, primarily focusing on detecting and quantifying trace amounts of volatile organic compounds (VOCs). The company's flagship product, the Voice200 SIFT-MS instrument, allows users to simultaneously identify and measure a wide range of gaseous chemicals. Additionally, Syft offers a Sample Collection Case for compact and portable sample collection, as well as a Sample Bag Flushing Station for cleaning sample bags. Their analytical solutions serve diverse sectors, including environmental monitoring, food and fragrance analysis, medical research, and oil and gas exploration. Syft Technologies distributes its products through a network of partners across Europe and maintains operations in Christchurch, New Zealand; Warrington, UK; and Pittsburgh, Pennsylvania. Founded in 2002, the company is committed to providing innovative gas analysis technology that enhances air quality monitoring and improves research capabilities.

BioEcho Life Sciences specializes in the development and production of advanced technologies for molecular biology and diagnostics. The company focuses on manufacturing nucleic acid purification products designed to enhance laboratory workflows in a more convenient, robust, and sustainable manner. Utilizing a proprietary single-step purification technology, BioEcho offers innovative sample lysis and purification tools that facilitate rapid and high-quality extraction of nucleic acids. These tools serve a variety of sectors, including clinical diagnostics, biotechnology, agricultural, and industrial applications. By streamlining DNA and RNA extraction processes, BioEcho aims to improve efficiency compared to traditional methods, while also reducing inhibitors that can affect downstream PCR and sequencing applications.

ProtaGene is an analytical service provider specializing in the biopharmaceutical sector, particularly in the development of biologic therapeutics and cell and gene therapies. The company offers a comprehensive suite of protein and gene analytic capabilities, catering to the needs of biosimilar developers by facilitating the demonstration of biosimilarity. ProtaGene's services include peptide mapping, protein quantification, protein modification analysis, bioassays, impurity assessment, and detailed characterization of antibodies and related products. These offerings are designed to support clients throughout the product lifecycle, enabling advanced analytics that enhance biopharmaceutical development processes.

Magritek Limited specializes in the design and manufacture of benchtop nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) systems. Founded in 2004 and based in Wellington, New Zealand, with an additional office in Aachen, Germany, Magritek provides innovative, cryogen-free instruments for a variety of applications, including oil and gas, research, education, and portable markets. Their product offerings include ultra-compact NMR spectrometers for chemistry education, NMR rock core analyzers for hydrocarbon reservoir analysis, and portable NMR sensors known as NMR-MOUSE. The company also delivers systems such as Kea for research, a compact tomography system, and software for processing multi-dimensional NMR data. Magritek's solutions cater to industries such as pharmaceuticals, polymers, food, and petrochemicals, ensuring access to efficient and affordable analytical instruments for laboratories worldwide. The company serves its customers through a network of distributors.

Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.

GeneWerk GmbH is a specialized testing laboratory focused on cell and gene therapy, offering a range of preclinical and clinical trial patient sample analysis services. Founded in July 2014 by a team of experts including Prof. Dr. Christof von Kalle, the company is based in Heidelberg, Germany, and has strong ties to the German Cancer Research Center. GeneWerk provides various analytical products, including Vector Safety for viral vector integration site analysis, AAV vector quality control, immune repertoire analysis, qPCR, and gene editing on- and off-target analyses. The laboratory is committed to developing innovative analysis methods and ensures compliance with guidelines from regulatory bodies such as the U.S. Food and Drug Administration and the European Medicines Agency.

ALPCO Diagnostics is a manufacturer specializing in immunoassay-based products aimed at supporting both life science research and clinical diagnostics. The company develops a diverse range of specialty immunoassay products, including In Vitro Diagnostics (IVDs) and Research Use Only (RUO) assays. These products are designed to aid in the investigation, detection, diagnosis, and treatment of various health-related disorders and diseases. By providing scientists and healthcare professionals with essential testing solutions, ALPCO Diagnostics contributes to the advancement of research and enhances the quality of patient care.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.

New England Peptide, Inc. specializes in the design and manufacture of a wide range of peptides and related products. Its offerings include bioactive peptides, amino acids, phospho amino acids, pseudoprolines, and heavy amino acids, as well as peptide synthesis accessories and stable isotope standard tryptic peptides for protein identification. The company also provides custom polyclonal and monoclonal antibodies, along with analytical services such as amino acid analysis, liquid chromatography/mass spectrometry, sequencing, and sample preparation. Catering primarily to organizations involved in drug and vaccine discovery, New England Peptide sells products online and through distributors in Japan, Taiwan, and Korea. Founded in 1998 and headquartered in Harvard, Massachusetts, the company maintains an additional office in Cambridge, Massachusetts.

Vivitide is a manufacturer focused on producing peptides and polyclonal antibodies, catering to organizations involved in drug, vaccine, and diagnostic development. The company offers a range of services, including custom peptide synthesis and antibody packages, available for both small and large-scale industries. Its product offerings encompass peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, and resins, which are utilized in the treatment of various conditions such as cancer, diabetes, obesity, infections, and HIV. By providing high-quality and tailored solutions, Vivitide supports its clients in advancing their biomedical research and therapeutic applications.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

N2 Biomedical specializes in coating and surface treatment services for the medical device industry, focusing on products such as guidewires, core wires, hypo tubes, and forming mandrels. The company collaborates closely with healthcare and medical device manufacturers to provide a comprehensive range of services, from concept development to commercialization. N2 Biomedical offers flexible prototype work, as well as high-volume coating, finishing, and printing services. Its advanced coatings enhance the material characteristics of implantable and other medical devices, improving properties such as wear resistance, corrosion resistance, fracture toughness, lubricity, infection resistance, biocompatibility, aesthetics, and radiopacity. This enables clients in various healthcare sectors, including orthopedic and cardiovascular, to meet critical performance standards for their products.

Vibalogics GmbH is a contract development and manufacturing organization based in Cuxhaven, Germany, that specializes in providing comprehensive services for the biopharmaceutical industry, particularly in the fields of oncolytic viral therapies, gene therapies, and vaccines. Established in 2002 and formerly known as Bioprotect Research GmbH, the company offers a range of services that include process development, cell and virus banking, drug production, fill and finish, as well as quality control and stability testing. Vibalogics collaborates with pharmaceutical companies, biotechnology firms, and academic institutions across Europe, the United States, and the Asia-Pacific region, focusing on supporting the advancement of complex live biological products. Since 2019, it has operated as a subsidiary of Ampersand Management LLC.

Genome Diagnostics B.V., operating as GenDx, is a biotechnology company based in Utrecht, the Netherlands, specializing in the development and marketing of in vitro diagnostic tests and related services for transplantation. Founded in 2005, GenDx is a pioneer in Sequencing-Based Typing (SBT), providing high-resolution HLA typing products that utilize both Sanger and next-generation sequencing (NGS) techniques. Its product portfolio includes SBTexcellerator, SBTengine, and NGSengine, which facilitate accurate analysis of HLA loci, as well as high-throughput reagents and software solutions for diverse laboratory needs. In addition to its diagnostic products, GenDx offers educational courses and laboratory services, and collaborates with industry partners to enhance its offerings. The company distributes its products both directly and through specialized distributors, affirming its commitment to advancing transplantation diagnostics.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.

MedPharm Ltd., established in 1999, is a leading global provider of pharmaceutical research and development services, specializing in topical and transdermal products. Based in Guildford, UK, with a U.S. office in Durham, North Carolina, the company offers expertise in dermatological, nail, eye, airway, mucosal membrane, and transdermal product development. MedPharm's services encompass formulation development, performance testing, and analytical services, utilizing proprietary models to reduce risk and accelerate development times for both generic and proprietary pharmaceutical customers. The company's expertise is recognized by regulators and investors, with established Centres of Excellence in both the UK and the U.S.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products focused on cell analysis for life science and biomedical research. Established in 2003 and based in Lawrence, Massachusetts, Nexcelom offers a range of products including the Cellometer, which uses bright field and fluorescence imaging modes to count and analyze cell lines and primary cells, and the Celigo, a high-throughput image cytometry system designed for both adherent and suspension cells in microwell plates. In addition to these instruments, the company provides fluorescent reagents and kits for cell counting and cell-based assays, catering to various research fields such as immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation.

Detector Technology, Inc. is a prominent manufacturer of products and systems tailored for OEM and equipment manufacturers. Specializing in Channel Electron Multipliers, Glass Extrusion & Fabrication, and Motion Control Products, DeTech operates a cutting-edge fabrication and production facility. With a focus on delivering manufacturing excellence and ensuring customer satisfaction, Detector Technology has built a strong reputation over the past two decades as a trusted provider in the industry.

Adaptas Solutions is a strategic original equipment manufacturer (OEM) that specializes in providing contract manufacturing services for analytical and laboratory equipment. The company focuses on developing critical components and subsystems for gas chromatography, mass spectrometry, and liquid chromatography applications. Its product offerings include electron multipliers, filaments, power supplies, and ion optic grids, as well as components for liquid handling and lab automation. By supplying high-quality products, Adaptas Solutions enables manufacturers of analytical and laboratory equipment to enhance their production processes and meet the demands of their respective markets.

LakePharma is a contract research organization (CRO) based in the San Francisco Bay Area that provides a comprehensive suite of biologics services aimed at the pharmaceutical and biotechnology industries. The company specializes in antibody and protein engineering, cell line development, and protein production, offering end-to-end solutions that encompass antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma employs in-house technology platforms to deliver high-quality, cost-effective services, with a focus on efficiency in both small and large-scale production processes. Each project is managed by a dedicated study director to ensure timely and transparent communication, while clients can access real-time project data through a secure cloud-based portal. LakePharma adheres to Good Laboratory Practices (GLP) to maintain the quality and integrity of study data, and it can operate in compliance with FDA documentation requirements for nonclinical laboratory studies. All services are offered on a fee-for-service basis, ensuring a straightforward and royalty-free engagement model for clients.

Corpus Medical Inc. specializes in consulting services for the medical device industry, offering expertise in the design, development, and manufacturing of advanced technology catheters. The company focuses on supporting device manufacturers in the electrophysiology, peripheral vascular, and cardiovascular markets. Its contract development and manufacturing services are tailored to the creation and commercialization of innovative interventional medical devices and catheter-based delivery systems. By streamlining the process from concept to market, Corpus Medical aims to enhance the efficiency with which customers can bring their products to market.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Brammer Bio, LLC specializes in the development and manufacturing of cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, and clinical and commercial supply of drug substances and formulated products. Brammer Bio focuses on supporting the production of autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications. With facilities in Alachua, Florida, and plans for a new site in Lexington, Massachusetts, the company aims to enhance its capacity for large-scale manufacturing and clinical support. As a contract development and manufacturing organization, Brammer Bio collaborates with biopharma clients to facilitate the delivery of innovative therapies, ensuring regulatory compliance and accelerating the commercialization of novel medicines.

Avista Pharma Solutions is a contract testing, development, and manufacturing organization that operates across three locations in Agawam, Massachusetts; Durham, North Carolina; and Longmont, Colorado. The company provides a wide range of services to clients in the pharmaceutical, animal health, and medical device sectors. These services include early drug development, active pharmaceutical ingredient (API) and drug product development, as well as compliant Good Manufacturing Practice (cGMP) manufacturing. Additionally, Avista offers standalone analytical and microbiology testing support, facilitating the development of newly created medicinal drugs. With over 200,000 square feet of laboratory and manufacturing space, Avista Pharma Solutions plays a vital role in the lifecycle of drug development and testing.

Gyros Protein Technologies AB is a Swedish company specializing in solutions for peptide synthesis and bioanalysis, aimed at enhancing biomolecule performance and productivity in various scientific fields. Founded in 2016 and headquartered in Uppsala, the company offers a range of peptide synthesizer platforms, including PurePep Chorus, Tribute, Prelude X, Symphony X, and Sonata, which provide high purity and flexibility for the synthesis of peptides. Additionally, Gyros Protein Technologies develops proprietary nanoliter-scale immunoassay platforms, such as Gyrolab xPand and Gyrolab xP workstation, utilized by professionals in pharmaceutical, biotechnology, contract research, and contract manufacturing sectors for bioanalytical applications. These technologies support critical processes such as pharmacokinetics, immunogenicity assessments, and the quantification of bioprocess-related impurities. By offering advanced tools for peptide synthesis and bioanalysis, Gyros Protein Technologies accelerates the discovery, development, and manufacturing of biotherapeutics. It operates as a subsidiary of Mesa Laboratories, Inc.

GENEWIZ, Inc. is a global contract research organization specializing in genomics and DNA sequencing services. Founded in 1999 and headquartered in South Plainfield, New Jersey, the company serves a diverse clientele, including pharmaceutical, biotechnology, academic, agricultural, clinical, and government institutions. GENEWIZ offers a comprehensive range of services, including Sanger DNA sequencing, gene synthesis, molecular biology techniques, genomic mutation analysis, and bioinformatics, all designed to enhance research productivity and efficiency. The company is also equipped to provide regulatory-compliant laboratory services for FDA applications, including RNA/DNA identity studies and SNP testing. With a focus on delivering high-quality data and exceptional technical support, GENEWIZ is committed to accelerating scientific discovery and advancing translational medicine. The company operates multiple locations across the United States and internationally in China, the United Kingdom, France, Germany, and Japan, solidifying its position as a preferred partner in the life sciences sector. As of November 2018, GENEWIZ operates as a subsidiary of Brooks Automation, Inc.

Azurity Pharmaceuticals is a pharmaceutical company dedicated to developing and marketing drug products that cater to patients with unmet medical needs. The company focuses on creating innovative medicines for various conditions, including attention deficit hyperactivity disorder (ADHD), hypertension, and congestive heart failure. A significant emphasis is placed on developing and commercializing oral liquid medications, which are particularly beneficial for children, elderly patients, and others who may struggle to swallow pills or tablets. In addition to these areas, Azurity also produces medications like antimicrobial agents and mouthwashes, enhancing the ability of pharmacists to provide better alternatives to traditionally compounded medications.

Elite One Source Nutritional Services, Inc., established in 2013 and headquartered in Missoula, Montana, specializes in contract manufacturing services for nutritional and dietary supplements. The company operates as a subsidiary of DCC Health & Beauty Solutions Limited. Through its manufacturing capabilities, Elite One Source caters to businesses seeking to produce high-quality dietary products, ensuring compliance with industry standards and regulations.

NutraMed, Inc. is a Chino, California-based company that specializes in the development, manufacturing, and marketing of nutritional supplement products, including vitamins in tablet, capsule, and powder forms. Founded in 1998, NutraMed provides a variety of manufacturing services such as blending, granulation, tableting, and timed release formulation. The company also produces bilayer tablets, various tablet coatings, and offers two-piece hard-shell encapsulation. In addition to its core product offerings, NutraMed provides packaging solutions including stick-packs, multi-packs, blister cards, and specialized powder and tablet packaging. The company is dedicated to serving customers both in the United States and internationally.

Sanova Dermatology, based in Austin, Texas, is a comprehensive dermatology center that provides both cosmetic and medical skin care services. The clinic specializes in various treatments, including wrinkle reduction, acne management, and skin cancer care. Their offerings encompass medical dermatology, surgical procedures such as Mohs micrographic surgery, and aesthetic treatments like laser procedures, dermal fillers, and Botox. With a focus on individualized care, Sanova Dermatology aims to address the unique aesthetic and medical needs of each patient through a team of experienced professionals.

Willow Laboratories is a multifaceted company specializing in cannabis packaging and clinical laboratory services. The firm offers packaging solutions tailored for craft cannabis, as well as extract and formulation services. In addition to its cannabis-related operations, Willow Laboratories provides clinical and forensic toxicology laboratory services, including urine, hair, and saliva testing. These services cater to a diverse clientele, including healthcare providers, treatment centers, and other laboratories, ensuring a comprehensive approach to both the cannabis and healthcare industries.

Bioventus LLC is a medical technology company specializing in orthobiologic solutions aimed at enhancing bone healing and managing osteoarthritis. The company offers a range of products, including active healing therapies that support the recovery of bone fractures and alleviate chronic pain associated with osteoarthritis. Its portfolio features injection therapies for osteoarthritic joints, surgical orthobiologics, and bone healing solutions that promote the body’s natural healing processes. Key offerings include the EXOGEN Ultrasound Bone Healing System and various joint fluid therapies. Bioventus is recognized for its innovative and effective products, which adhere to high quality standards and evidence-based practices. Headquartered in Durham, North Carolina, Bioventus employs around 500 people and generates approximately $240 million in annual revenue. The company operates a distribution network to make its products available to healthcare providers. Bioventus was established in 2011, evolving from the Biologics Division of Smith & Nephew.

CoreLab Partners is a biotech company that provides services related to cardio health monitoring and also provides technological support.

Nitinol Devices & Components (NDC), based in Fremont, California, is a privately held medical device company specializing in Nitinol technology. The company offers comprehensive services in manufacturing, research, development, and regulatory support, focusing on the medical sector. NDC is dedicated to advancing its capabilities to address the increasing demand for its shape-memory and superelastic Nitinol products, which are essential in various medical applications. Through its commitment to innovation and quality, NDC plays a significant role in the evolving landscape of medical devices.

Blue Sky Biotech, Inc. is a preclinical contract research organization based in Worcester, Massachusetts, specializing in pharmaceutical research and development. The company provides a range of services, including gene cloning, protein expression, protein purification, and assay development. As a trusted partner to nine of the top ten pharmaceutical companies, Blue Sky Biotech has established a strong reputation in the industry for enhancing productivity in early discovery biology processes. By alleviating the labor-intensive tasks associated with scientific research, Blue Sky enables scientists to focus on key experimentation and innovative theory exploration. Through its commitment to improving the efficiency of the drug discovery process, Blue Sky Biotech contributes to advancements that aim to extend human lifespan and promote overall health.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.

Signature Genomic Laboratories, based in Spokane, Washington, specializes in molecular cytogenetic diagnostic services. The company offers a range of diagnostic testing for both pediatric and adult patients, as well as prenatal testing services. Its offerings include fluorescence in situ hybridization (FISH) analysis of clinically relevant genetic loci, interpretation of genome microarrays, and G-banded karyotype analysis. By providing comprehensive genetic testing and analysis, Signature Genomic Laboratories aims to support clinicians in diagnosing genetic conditions and informing patient care.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Agilux Laboratories, Inc. is a contract research organization based in Worcester, Massachusetts, founded in 2007. The company specializes in supporting drug discovery, pre-clinical, and clinical research for the biotech and pharmaceutical industries. Agilux Laboratories offers a comprehensive range of services, including drug metabolism and pharmacokinetics (DMPK), discovery bioanalytical, good laboratory practice (GLP) bioanalytical, as well as in vivo and in vitro testing. The organization also provides immunoassays for biomarker analysis. By focusing on bioanalytical and pharmacokinetic/pharmacodynamic testing, Agilux Laboratories assists its clients in navigating the complexities of drug development and regulatory requirements. The company operates as a subsidiary of Charles River Laboratories International, Inc.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

ChanTest specializes in ion channel testing services, offering a comprehensive library of validated human ion channel-expressing cell lines tailored for the pharmaceutical and biotech sectors. The company provides a range of services, including functional screens to profile drug candidates and assess their performance during the drug discovery process. Additionally, ChanTest offers in vitro Good Laboratory Practice (GLP) service products focused on cardiac risk assessment. By collaborating closely with clients, ChanTest aims to expedite the drug development process, ultimately contributing to the creation of safer and more effective medications.

Cequent Pharmaceuticals is an early-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative RNA interference (RNAi)-based therapeutics to prevent and treat various human diseases, including inflammatory conditions and cancer. The company utilizes its proprietary TransKingdom RNA interference (tkRNAi) technology, designed to safely and effectively deactivate specific genes associated with diseases using non-pathogenic bacteria to deliver RNAi directly into cells. Currently, Cequent's lead drug candidates, which target colon cancer prevention and inflammatory bowel disease, are in pre-clinical development. Established in 2006, Cequent originated from pioneering research at the Institut Pasteur in Paris and the Beth Israel Deaconess Medical Center/Harvard Medical School. In 2010, the company was acquired by Marina Biotech, Inc.

CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.

Magellan Diagnostics, Inc. is a medical device company focused on developing and manufacturing point-of-care systems and clinical laboratory instruments for lead testing. The company offers a range of products, including LeadCare II, a blood lead testing system, and LeadCare Ultra, designed for laboratory use. Additionally, LeadCare Plus serves facilities with lower testing volumes. Magellan also provides analytical services related to lead and heavy metal exposure, aiding in the monitoring of exposure for employees and the general public. Founded in 2004 and headquartered in Billerica, Massachusetts, Magellan has its roots in the late 1960s with the development of a novel blood lead measurement technique by MIT graduates. The company has since evolved to create portable instruments that enhance accessibility to lead testing in various settings, helping to identify and protect individuals at risk of lead exposure.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.

Medifacts International, Inc. specializes in cardiovascular safety monitoring services tailored for the pharmaceutical and biotech sectors. Founded in 1985 and headquartered in Rockville, Maryland, with additional offices in Germany and China, the company offers a range of services, including electrocardiogram (ECG) services, digital Holter monitoring, ambulatory blood pressure monitoring, and telemedicine. It also provides consulting and medical writing services, which encompass program and protocol design, statistical analysis, regulatory guidance, and expert reporting for clinical trials. Moreover, Medifacts International delivers medical imaging services and education seminars, enhancing its offerings in cardiac safety and patient monitoring. The company was acquired by CoreLab Partners in 2010.

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.

ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.

Panacos Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small-molecule oral drugs targeting human immunodeficiency virus (HIV) and other viral diseases. Founded in 1999 and based in Watertown, Massachusetts, the company employs innovative technologies to identify novel targets in the viral life cycle, particularly in areas such as virus maturation and fusion. Its product pipeline includes advanced programs aimed at inhibiting HIV maturation, representing second- and third-generation therapeutic options.

Proficiency, Inc. specializes in product knowledge integration and CAD interoperability solutions, facilitating the sharing of product data among manufacturers and suppliers across various engineering and manufacturing sectors. The company's offerings include product knowledge migration, which provides a structured approach to meet migration requirements, and supplier delivery solutions aimed at original equipment manufacturers and higher-tier suppliers. Key products include Collaboration Gateway V7.0, which allows for the transfer of comprehensive product knowledge between different CAD systems, and Completion Wizard, an interactive tool for managing the completion process. Additionally, Proficiency provides CAD translation services, consulting on migration and supplier delivery strategies, and implementation services such as training and support. The company primarily serves clients in the automotive, aerospace, defense, and heavy machinery industries. Founded in 1998 and based in Marlborough, Massachusetts, Proficiency operates as a subsidiary of ITI TranscenData.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

Viadux, headquartered in Carole Park, Australia, is a subsidiary of Reece Limited. It specializes in providing in-building broadband access solutions to the telecommunications and cable industries, focusing on small-to-medium enterprises and residential customers in multi-tenant units. The company partners with service providers to deliver high-speed data, video, and voice services.

Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.

Ensemble Communications is a develops wireless infrastructure equipment for high-speed local broadband access applications.

Cyclis Pharmaceuticals is focused on researching and developing small-molecule drugs aimed at treating cancer. The company employs a novel technology that selectively targets cancer cells while preserving normal cells by restoring and activating cellular checkpoints that are often defective in cancer. This approach is designed to correct apoptotic and cellular checkpoint defects commonly found in cancer cells, leading to higher efficacy and reduced toxicity compared to traditional cancer therapies. Through its innovative methods, Cyclis Pharmaceuticals strives to improve treatment outcomes for cancer patients.

Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.